Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
157 studies found for:    "restless legs syndrome"
Show Display Options
Download search resultsDownload the search results for:
"restless legs syndrome" (157 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Completed
Has Results
Bupropion and Restless Legs Syndrome
Condition: Restless Legs Syndrome
Interventions: Drug: Bupropion;   Drug: Placebo
2 Active, not recruiting Glutamate, Hyperarousal and Restless Legs Syndrome
Condition: Restless Legs Syndrome
Intervention:
3 Terminated Efficacy and Safety Study of Aplindore in Patients With Restless Legs Syndrome
Condition: Restless Legs Syndrome
Intervention: Drug: aplindore MR tablets or Placebo
4 Recruiting Autonomic Function and Cardiovascular Risk in Restless Legs Syndrome
Condition: Restless Legs Syndrome
Interventions: Drug: Pramipexole;   Drug: Placebo
5 Completed Ropinirole XR (Extended Release) In Patients With Restless Legs Syndrome
Condition: Restless Legs Syndrome
Intervention: Drug: Ropinirole Extended Release (XR)
6 Completed An Extension Trial to Investigate Long-Term Treatment With Transdermal Rotigotine in Idiopathic Restless Legs Syndrome
Condition: Restless Legs Syndrome
Intervention: Drug: Rotigotine
7 Completed Four Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Legs Syndrome
Condition: Restless Legs Syndrome
Intervention: Drug: Rotigotine
8 Completed A Clinical Research Study Evaluating Ropinirole Treatment For Restless Legs Syndrome (RLS)
Condition: Restless Legs Syndrome
Intervention: Drug: ropinirole
9 Completed A Sleep Lab Trial to Investigate the Efficacy and Safety of Transdermal Rotigotine in Subjects With Idiopathic Restless Legs Syndrome
Condition: Restless Legs Syndrome
Intervention: Drug: Rotigotine
10 Completed
Has Results
Botulinum Toxin to Treat Restless Legs Syndrome
Condition: Restless Legs Syndrome
Intervention: Drug: Botulinum Toxin A
11 Completed
Has Results
Polysomnography Study Of Pregabalin And Pramipexole Versus Placebo In Patients With Restless Legs Syndrome And Associated Sleep Disturbance
Condition: Restless Legs Syndrome
Interventions: Drug: pregabalin;   Drug: placebo;   Drug: pramipexole
12 Withdrawn 12-Week Efficacy And Safety Of Pregabalin In Treating Restless Legs Syndrome (RLS) Subjects
Condition: Restless Legs Syndrome
Interventions: Drug: Placebo;   Drug: pregabalin
13 Recruiting A Study on the Use of the MMF07 Foot Massager and Heat Therapy Treatments for Restless Leg Syndrome
Condition: Restless Legs Syndrome
Interventions: Device: MMF07 Foot Massager;   Device: Heat Therapy
14 Completed A Double Blind Crossover Trial of Levetiracetam (Keppra®) and Placebo in the Treatment of Restless Legs Syndrome (RLS)
Condition: Restless Legs Syndrome
Intervention: Drug: Levetiracetam (Keppra)
15 Completed
Has Results
Lyrica Dose Response Study With Restless Legs Syndrome (RLS) Patients
Condition: Restless Legs Syndrome
Interventions: Drug: placebo;   Drug: Pregabalin
16 Completed Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Condition: Restless Legs Syndrome
Intervention: Drug: Ropinirole Extended Release (XR)
17 Completed
Has Results
Clinical Evaluation of Ropinirole CR-RLS ( SK&F101468)Tablets in Restless Legs Syndrome
Condition: Restless Legs Syndrome
Intervention: Drug: ropinirole controlled release (CR)-RLS
18 Terminated Safety and Efficacy of Rasagiline in Restless Legs Syndrome
Condition: Restless Legs Syndrome
Interventions: Drug: rasagiline;   Drug: placebo (sugar pill)
19 Completed Three Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Leg Syndrome
Condition: Restless Legs Syndrome
Intervention: Drug: Rotigotine
20 Completed Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
Condition: Restless Legs Syndrome
Interventions: Drug: IPX159;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.